Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Julian J Freen-van Heeren"'
Autor:
Carola Berking, Gerold Schuler, Olaf Wolkenhauer, Annelies W Turksma, Heiko Bruns, Julio Vera, Martin Eberhardt, Manuel Wiesinger, Beatrice Schuler-Thurner, Cindy Flamann, Markus Vincent Heppt, Shailendra Gupta, Christopher Lischer, Johannes Berges, Esther Güse, Anja Wessely, Adrian Weich, Jimmy Retzlaff, Jan Dörrie, Niels Schaft, Johannes März, Harald Knorr, Krishna Pal Singh, Elias Andreas Thomas Koch, Nadine D van Kleef, Julian J Freen-van Heeren, Bettina Hohberger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 5 (2024)
Background Tumor-associated antigens and their derived peptides constitute an opportunity to design off-the-shelf mainline or adjuvant anti-cancer immunotherapies for a broad array of patients. A performant and rational antigen selection pipeline wou
Externí odkaz:
https://doaj.org/article/f5b73ac9110f43bf9d82c89934e31442
Autor:
Julian J. Freen-van Heeren
Publikováno v:
BioTech, Vol 11, Iss 3, p 25 (2022)
Human immunodeficiency virus (HIV) infection can be controlled by anti-retroviral therapy. Suppressing viral replication relies on life-long medication, but anti-retroviral therapy is not without risks to the patient. Therefore, it is important that
Externí odkaz:
https://doaj.org/article/b57ecde160414766a448dac2b26bd77a
Publikováno v:
The CRISPR Journal. 6:87-89
Autor:
Rosa De Groot, Marleen M. Van Loenen, Aurélie Guislain, Benoît P. Nicolet, Julian J. Freen-Van Heeren, Onno J.H.M. Verhagen, Michel M. Van Den Heuvel, Jeroen De Jong, Patrick Burger, C.Ellen Van Der Schoot, Robbert M. Spaapen, Derk Amsen, John B. A. G. Haanen, Kim Monkhorst, Koen J. Hartemink, Monika C. Wolkers
Publikováno v:
OncoImmunology, Vol 8, Iss 11 (2019)
Non-small cell lung cancer (NSCLC) is the second most prevalent type of cancer. With the current treatment regimens, the mortality rate remains high. Therefore, better therapeutic approaches are necessary. NSCLCs generally possess many genetic mutati
Externí odkaz:
https://doaj.org/article/f448f39206b24f9d9d87e6d41805f604
Autor:
Julian J. Freen-van Heeren
Publikováno v:
BioTech, Vol 10, Iss 4, p 21 (2021)
Many techniques are currently in use to study microbes. These can be aimed at detecting, identifying, and characterizing bacterial, fungal, and viral species. One technique that is suitable for high-throughput analysis is flow cytometry-based fluores
Externí odkaz:
https://doaj.org/article/f6631c1b5d904fb5a68fc145b60abcf6
Publikováno v:
Immunology & Cell Biology. 101:374-376
Autor:
Fiamma Salerno, Aurelie Guislain, Julian J. Freen-Van Heeren, Benoit P. Nicolet, Howard A. Young, Monika C. Wolkers
Publikováno v:
OncoImmunology, Vol 8, Iss 2 (2019)
Protective T cell responses against tumors require the production of Interferon gamma (IFN-γ). However, tumor-infiltrating T cells (TILs) gradually lose their capacity to produce IFN-γ and therefore fail to clear malignant cells. Dissecting the und
Externí odkaz:
https://doaj.org/article/3464888a53fa49779ff2a55a060dfefc
Autor:
null Ammarina Beumer‐Chuwonpad, null Floris P.J. van Alphen, null Natasja A.M. Kragten, null Julian J. Freen‐ van Heeren, null Maria Rodriguez Gomez, null Arthur J. Verhoeven, null Maartje van den Biggelaar, null Klaas P.J.M. van Gisbergen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bcde7610e1c5a48f5f7b76152583cd2
https://doi.org/10.1002/eji.202249918/v3/response1
https://doi.org/10.1002/eji.202249918/v3/response1
Autor:
Ammarina, Beumer-Chuwonpad, Floris P J, van Alphen, Natasja A M, Kragten, Julian J, Freen-van Heeren, Maria, Rodriguez Gomez, Arthur J, Verhoeven, Maartje, van den Biggelaar, Klaas P J M, van Gisbergen
Publikováno v:
European journal of immunologyReferences.
Memory CD8
Autor:
Floris P. J. van Alphen, Sander Engels, Julian J Freen-van Heeren, Natali Paravinja, Anouk Jurgens, Fiamma Salerno, Aurelie Guislain, Branka Popović, Monika C. Wolkers, Benoit P Nicolet, Maartje van den Biggelaar
Publikováno v:
Cell Reports. 42:112419
Potent T cell responses against infections and malignancies depend on the release of effector molecules, such as pro-inflammatory cytokines. Because effector molecules can be toxic, their production is tightly regulated through post-transcriptional e